The CHORD protein CHP-1 regulates EGF receptor trafficking and signaling in


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
13 02 2020
Historique:
received: 09 08 2019
accepted: 12 02 2020
pubmed: 14 2 2020
medline: 15 4 2021
entrez: 14 2 2020
Statut: epublish

Résumé

The intracellular trafficking of growth factor receptors determines the activity of their downstream signaling pathways. Here, we show that the putative HSP-90 co-chaperone CHP-1 acts as a regulator of EGFR trafficking in

Identifiants

pubmed: 32053105
doi: 10.7554/eLife.50986
pii: 50986
pmc: PMC7062474
doi:
pii:

Substances chimiques

CHORDC1 protein, human 0
HSP90 Heat-Shock Proteins 0
Phosphate-Binding Proteins 0
EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Swiss National Science Foundation
ID : 31003A-166580
Pays : Switzerland
Organisme : NIH HHS
ID : P40 OD010440
Pays : United States

Informations de copyright

© 2020, Haag et al.

Déclaration de conflit d'intérêts

AH, MW, AH, AH No competing interests declared

Références

Biochim Biophys Acta. 2012 Mar;1823(3):668-73
pubmed: 21889547
Exp Cell Res. 2009 Feb 15;315(4):683-96
pubmed: 19278030
Nat Rev Mol Cell Biol. 2008 Nov;9(11):887-901
pubmed: 18946477
Neoplasia. 2012 Aug;14(8):670-7
pubmed: 22952420
Cell. 1998 Sep 18;94(6):761-71
pubmed: 9753323
Biochim Biophys Acta. 2012 Mar;1823(3):624-35
pubmed: 21951723
Nat Genet. 2008 Nov;40(11):1375-83
pubmed: 18953339
Cell. 1996 Apr 19;85(2):195-204
pubmed: 8612272
Nat Cell Biol. 2001 Oct;3(10):891-6
pubmed: 11584270
Mol Biol Cell. 2002 May;13(5):1778-91
pubmed: 12006669
EMBO Rep. 2002 Oct;3(10):944-50
pubmed: 12370207
Front Pharmacol. 2015 Nov 24;6:283
pubmed: 26635612
Methods. 2003 Aug;30(4):313-21
pubmed: 12828945
Development. 1998 Mar;125(6):1083-93
pubmed: 9463355
Hum Mol Genet. 2013 Feb 15;22(4):646-55
pubmed: 23118353
PLoS Genet. 2015 May 15;11(5):e1005236
pubmed: 25978500
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Proteins. 2017 Aug;85(8):1529-1549
pubmed: 28486782
Nat Rev Mol Cell Biol. 2006 Jul;7(7):505-16
pubmed: 16829981
Science. 1997 Aug 22;277(5329):1103-6
pubmed: 9262480
Cell. 1986 Mar 14;44(5):761-72
pubmed: 3753901
Mol Cell. 2011 Jul 22;43(2):229-41
pubmed: 21777812
Mech Dev. 2002 Dec;119 Suppl 1:S203-9
pubmed: 14516686
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Biophys J. 2004 Jun;86(6):3993-4003
pubmed: 15189895
Mol Biol Cell. 2006 Mar;17(3):1286-97
pubmed: 16394106
Dev Biol. 2016 Aug 1;416(1):123-135
pubmed: 27288708
Genetics. 2000 May;155(1):85-104
pubmed: 10790386
Nature. 1990 Dec 6;348(6301):503-9
pubmed: 2123303
PLoS Genet. 2014 May 01;10(5):e1004341
pubmed: 24785082
Gene. 2007 Oct 1;400(1-2):166-73
pubmed: 17681718
Nature. 2002 Dec 12;420(6916):686-90
pubmed: 12478297
WormBook. 2006 Feb 11;:1-19
pubmed: 18050474
Worm. 2013 Jan 1;2(1):e24059
pubmed: 24058864
Genetics. 1974 May;77(1):71-94
pubmed: 4366476
Mol Biol Cell. 1999 Jun;10(6):2087-100
pubmed: 10359617
Mol Cell Proteomics. 2010 Feb;9(2):255-70
pubmed: 19875381
EMBO J. 1991 Dec;10(12):3959-70
pubmed: 1935914
Cell Cycle. 2011 Nov 1;10(21):3678-83
pubmed: 22037254
EMBO J. 2006 Jun 7;25(11):2347-57
pubmed: 16688213
PLoS One. 2012;7(4):e36489
pubmed: 22558469
J Biol Chem. 1991 Apr 25;266(12):7503-8
pubmed: 2019581
FEBS Lett. 2003 Sep 11;551(1-3):47-52
pubmed: 12965203
PLoS Genet. 2014 Oct 16;10(10):e1004728
pubmed: 25329472
G3 (Bethesda). 2018 May 4;8(5):1535-1544
pubmed: 29507057
Dev Cell. 2009 Aug;17(2):187-98
pubmed: 19686680
Development. 2004 Jan;131(1):143-51
pubmed: 14660442
Trends Biochem Sci. 2017 Oct;42(10):799-811
pubmed: 28784328
Life Sci Alliance. 2019 May 24;2(3):
pubmed: 31126994
WormBook. 2005 Jun 25;:1-28
pubmed: 18050418
J Cell Biol. 2015 Nov 23;211(4):775-84
pubmed: 26572623
Science. 2001 Feb 9;291(5506):1055-8
pubmed: 11161219
Cell. 2013 Jun 20;153(7):1435-47
pubmed: 23791175
Nature. 2002 Jan 3;415(6867):92-6
pubmed: 11780124
Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1878-82
pubmed: 8127899
Dev Cell. 2014 Sep 8;30(5):625-36
pubmed: 25155554
Nat Methods. 2009 May;6(5):343-5
pubmed: 19363495
Development. 1996 Jan;122(1):97-111
pubmed: 8565857
Cell. 2004 Sep 17;118(6):795-806
pubmed: 15369677
Genes Dev. 1997 Oct 15;11(20):2715-28
pubmed: 9334333
J Cell Sci. 2020 Jan 23;133(2):
pubmed: 31907206

Auteurs

Andrea Haag (A)

Institute of Molecular Life Sciences, University of Zürich, Winterthurerstrasse, Switzerland.
Molecular Life Science Zürich PhD Program, Zürich, Switzerland.

Michael Walser (M)

Institute of Molecular Life Sciences, University of Zürich, Winterthurerstrasse, Switzerland.

Adrian Henggeler (A)

Institute of Molecular Life Sciences, University of Zürich, Winterthurerstrasse, Switzerland.

Alex Hajnal (A)

Institute of Molecular Life Sciences, University of Zürich, Winterthurerstrasse, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH